CollPlant Biotechnologies (CLGN) Capital Expenditures (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Capital Expenditures of -$15000.0 for Q4 2025, down 1400.0% on a QoQ basis from -$1000.0 in Q3 2025, and up 74.58% year-over-year from -$8592.2 in Q4 2024.
CollPlant Biotechnologies (CLGN) Capital Expenditures (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Capital Expenditures history runs 8 years deep, the most recent figure standing at -$15000.0 for Q4 2025.
- Quarterly Capital Expenditures rose 74.58% year-over-year to -$15000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$78000.0 (up 83.85% YoY) and the FY2025 annual result came in at -$28000.0, up 94.2% from the prior year.
- Capital Expenditures was -$15000.0 for Q4 2025 at CollPlant Biotechnologies, down from -$1000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at -$1000.0 in Q3 2025 and bottomed at -$1.4 million in Q4 2021.
- A 5-year average of -$321842.1 and a median of -$229000.0 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2021 — Capital Expenditures slumped 603.49% — and 2025, when it surged 99.29%.
- CollPlant Biotechnologies' Capital Expenditures stood at -$1.4 million in 2021, then increased by 10.78% to -$1.3 million in 2022, then soared by 82.03% to -$229000.0 in 2023, then surged by 74.24% to -$59000.0 in 2024, then surged by 74.58% to -$15000.0 in 2025.
- Business Quant data shows CLGN's Capital Expenditures at -$15000.0 in Q4 2025, -$1000.0 in Q3 2025, and -$3000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15,000.00 |
| Dec 31, 2025 | -15,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Sep 30, 2023 | -243,000.00 |
| Sep 30, 2023 | -243,000.00 |
| Jun 30, 2023 | -337,000.00 |
| Jun 30, 2023 | -337,000.00 |